Log in

NYSE:CDAYCeridian HCM Stock Price, Forecast & News

$83.75
-0.65 (-0.77 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$83.50
Now: $83.75
$86.76
50-Day Range
$63.28
MA: $74.84
$84.67
52-Week Range
$38.40
Now: $83.75
$87.00
Volume1.16 million shs
Average Volume1.46 million shs
Market Capitalization$12.15 billion
P/E Ratio164.22
Dividend YieldN/A
Beta1.68
Ceridian HCM Holding Inc. operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions. It also provides Bureau solutions for payroll and payroll-related services. Ceridian HCM Holding Inc. was incorporated in 2013 and is headquartered in Minneapolis, Minnesota.
Read More
Ceridian HCM logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.51 out of 5 stars


Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
CUSIPN/A
Phone952-853-8100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$824.10 million
Cash Flow$0.66 per share
Book Value$13.04 per share

Profitability

Net Income$78.70 million

Miscellaneous

Employees5,011
Market Cap$12.15 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CDAY News and Ratings via Email

Sign-up to receive the latest news and ratings for CDAY and its competitors with MarketBeat's FREE daily newsletter.

Ceridian HCM (NYSE:CDAY) Frequently Asked Questions

How has Ceridian HCM's stock been impacted by COVID-19 (Coronavirus)?

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CDAY shares have increased by 47.9% and is now trading at $83.75. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Ceridian HCM?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Ceridian HCM.

When is Ceridian HCM's next earnings date?

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Ceridian HCM.

How were Ceridian HCM's earnings last quarter?

Ceridian HCM Holding Inc (NYSE:CDAY) released its earnings results on Wednesday, May, 6th. The company reported $0.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.12 by $0.03. The company earned $222.70 million during the quarter, compared to the consensus estimate of $218.42 million. Ceridian HCM had a net margin of 9.03% and a return on equity of 1.80%. Ceridian HCM's quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.14 EPS. View Ceridian HCM's earnings history.

What price target have analysts set for CDAY?

15 brokers have issued 12-month price objectives for Ceridian HCM's shares. Their forecasts range from $45.00 to $85.00. On average, they anticipate Ceridian HCM's share price to reach $66.82 in the next twelve months. This suggests that the stock has a possible downside of 20.2%. View analysts' price targets for Ceridian HCM.

Has Ceridian HCM been receiving favorable news coverage?

Media headlines about CDAY stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Ceridian HCM earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Ceridian HCM.

Are investors shorting Ceridian HCM?

Ceridian HCM saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 7,780,000 shares, a drop of 21.3% from the June 15th total of 9,890,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the short-interest ratio is presently 5.5 days. Approximately 6.9% of the company's stock are short sold. View Ceridian HCM's Current Options Chain.

Who are some of Ceridian HCM's key competitors?

What other stocks do shareholders of Ceridian HCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Paycom Software (PAYC), Advanced Micro Devices (AMD), Costco Wholesale (COST), Alteryx (AYX), Shopify (SHOP) and Tesla (TSLA).

Who are Ceridian HCM's key executives?

Ceridian HCM's management team includes the following people:
  • Mr. David D. Ossip, Chairman & CEO (Age 52)
  • Mr. Arthur Gitajn, Exec. VP & CFO (Age 67)
  • Mr. Paul D. Elliott, Consultant (Age 53)
  • Ms. Leagh E. Turner, Pres (Age 47)
  • Mr. Christopher R. Armstrong, Exec. VP & COO (Age 50)

When did Ceridian HCM IPO?

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

What is Ceridian HCM's stock symbol?

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Who are Ceridian HCM's major shareholders?

Ceridian HCM's stock is owned by a number of retail and institutional investors. Top institutional investors include Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

Which institutional investors are buying Ceridian HCM stock?

CDAY stock was bought by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Ceridian HCM.

How do I buy shares of Ceridian HCM?

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ceridian HCM's stock price today?

One share of CDAY stock can currently be purchased for approximately $83.75.

How big of a company is Ceridian HCM?

Ceridian HCM has a market capitalization of $12.15 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe.

What is Ceridian HCM's official website?

The official website for Ceridian HCM is www.ceridian.com.

How can I contact Ceridian HCM?

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.